Catalyst Pharmaceuticals, Inc. (FRA:CN2)
Germany
· Delayed Price · Currency is EUR 19.51
-0.04 (-0.18%)
Last updated: Dec 5, 2025, 8:04 AM CET
Catalyst Pharmaceuticals Revenue
Catalyst Pharmaceuticals had revenue of $148.39M USD in the quarter ending September 30, 2025, with 15.31% growth. This brings the company's revenue in the last twelve months to $578.20M, up 25.56% year-over-year. In the year 2024, Catalyst Pharmaceuticals had annual revenue of $491.73M with 23.49% growth.
Revenue (ttm)
$578.20M
Revenue Growth
+25.56%
P/S Ratio
5.04
Revenue / Employee
$3.19M
Employees
181
Market Cap
2.49B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 491.73M | 93.53M | 23.49% |
| Dec 31, 2023 | 398.20M | 184.00M | 85.90% |
| Dec 31, 2022 | 214.20M | 73.37M | 52.10% |
| Dec 31, 2021 | 140.83M | 21.76M | 18.27% |
| Dec 31, 2020 | 119.07M | 16.77M | 16.39% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |